Biomerica (NASDAQ:BMRA) Issues Earnings Results

Biomerica (NASDAQ:BMRA) posted its quarterly earnings results on Tuesday. The company reported ($0.06) earnings per share (EPS) for the quarter, Zacks reports. Biomerica had a negative return on equity of 84.62% and a negative net margin of 111.89%.

Biomerica Stock Up 2.0 %

Shares of BMRA stock traded up $0.01 on Tuesday, reaching $0.33. The stock had a trading volume of 115,344 shares, compared to its average volume of 259,193. Biomerica has a 12 month low of $0.24 and a 12 month high of $1.35. The firm has a market capitalization of $5.51 million, a price-to-earnings ratio of -0.89 and a beta of -1.04. The firm’s 50-day moving average is $0.33 and its two-hundred day moving average is $0.34.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.